Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
1,265 people get DSCO articles and Market Currents by email alert.
Get email alerts on DSCO »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
PR Newswire (May 15, 2013)
-
PR Newswire (May 10, 2013)
-
PR Newswire (May 9, 2013)
-
PR Newswire (May 7, 2013)
-
PR Newswire (Mar 13, 2013)
-
PR Newswire (Feb 13, 2013)
-
GlobeNewswire (Jan 17, 2013)
To learn more about Seeking Alpha Pro, click here.
-
Discovery Labs Anticipating Active Year EndMike Havrilla • Fri, Sep 19, 2008
-
Small Biotech Companies: Please Tread CarefullyDoolan Wesley • Tue, Jun 26, 2012
-
PR Newswire (May 15, 2013)
-
PR Newswire (May 10, 2013)
-
PR Newswire (May 9, 2013)
-
PR Newswire (May 7, 2013)
-
PR Newswire (Mar 13, 2013)
-
PR Newswire (Feb 13, 2013)
-
GlobeNewswire (Jan 17, 2013)
-
PR Newswire (Jan 4, 2013)
-
PR Newswire (Jan 3, 2013)
-
PR Newswire (Nov 28, 2012)
-
GlobeNewswire (Nov 20, 2012)
-
PR Newswire (Nov 14, 2012)
-
PR Newswire (Nov 8, 2012)
-
PR Newswire (Oct 24, 2012)
-
GlobeNewswire (Sep 4, 2012)
DSCO vs. ETF Alternatives
Company Description
Discovery Laboratories, Inc. (referred to as “we,” “us,” or the “Company”) is a Delaware corporation, with our principal offices located at 2600 Kelly Road, Suite 100, Warrington, Pennsylvania. We were incorporated as a Delaware corporation in 1992. Our telephone number is 215-488-9300 and our... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, May 7, 7:58 AM Discovery Labs (DSCO): Q1 EPS of -$0.29 misses by $0.03. Revenue of $72K beats by $62K. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Wednesday, March 13, 7:49 AM Discovery Labs (DSCO): Q4 EPS of -$0.16 beats by $0.12. Revenue of $195K beats by $135K. (PR) Comment! [Earnings, Breaking News, Healthcare]
-
ZetaKap
3 High-Growth, Low-Debt Healthcare MicroCaps http://bit.ly/PfbYi1 $DSCO $INMD $RTIX @ZetaKap - View all 0 replies
-
reachmygoals1
Buyout Rumors? Is it possible DSCO's CEO who is a former Johnson & Johnson exec work out a deal with his old company? - View all 0 replies
-
Michael Bryant
Congratulations to czfarrah61601 for picking Discovery Labs (DSCO), who's shares jumped on approval for lung drug. http://reut.rs/zdC11H - View all 3 replies
-
-
-
Michael Bryant
Anybody have any news about Discovery Laboratories (DSCO)? Should one buy into or hold into Tuesday's FDA decision? - View all 4 replies
-
-
-
reachmygoals1
Surfaxin has good chance of approval on March 6. DSCO is coiling itself for a huge run soon. - View all 0 replies
LATEST REPLIES
-
Michael Bryant
Congratulations to czfarrah61601 for picking Discovery Labs (DSCO), who's shares jumped on approval for lung drug. http://reut.rs/zdC11H - View all 3 replies
-
-
-
Michael Bryant
Anybody have any news about Discovery Laboratories (DSCO)? Should one buy into or hold into Tuesday's FDA decision? - View all 4 replies
-
-


